Arcus Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good afternoon. Thanks for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and we're pleased to have Arcus Biosciences with us. We have Terry Rosen, CEO; Juan Jaen, President; and Bill Grossman, Chief Medical Officer.
Questions & Answers
And with that, I'll throw out our first question here on the recent collaboration. So you recently announced a 10-year collaboration with Gilead. Can you just recap for us the thinking behind this partnership and the strategic decision to choose Gilead versus more established pharma players within the I-O field itself, and then walk us through this agreement and what it means for Arcus?
Sure. So first of all, thank you, Salveen, for including in this -- us in this. We appreciate that. And to all those who are on the line, thank you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |